Oramed -Model ORMD 0901 -Oral GLP-1 Capsule for T2DM
Glucagon-like peptide-1 (GLP-1) is an incretin hormone that stimulates the secretion of insulin from the pancreas. Exenatide, a GLP-1 analog, is currently marketed in injectable form, and is indicated for treatment of type 2 diabetes. Exenatide induces insulin release at increased glucose levels and causes a feeling of satiety, which results in reduced food intake and weight loss.
Most popular related searches
injectable forms
insulin release
glucose level
diabetes
insulin induced
pancreas
hormone secretion
insulin secreting
insulin secretion
diabetes type
Oramed’s oral GLP-1 capsule based on the company’s PODTM technology could significantly increase compliance and become a valuable tool in the treatment of diabetes.